{"cik":891293,"taxonomy":"us-gaap","tag":"IntangibleAssetsNetExcludingGoodwill","label":"Intangible Assets, Net (Excluding Goodwill)","description":"Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.","entityName":"CTI BIOPHARMA CORP","units":{"USD":[{"end":"2021-12-31","val":0,"accn":"0000891293-22-000026","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-12"},{"end":"2021-12-31","val":0,"accn":"0000891293-22-000043","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-08"},{"end":"2021-12-31","val":0,"accn":"0000891293-22-000054","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-07"},{"end":"2021-12-31","val":0,"accn":"0000891293-23-000011","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-06","frame":"CY2021Q4I"},{"end":"2022-03-31","val":24815000,"accn":"0000891293-22-000026","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-12","frame":"CY2022Q1I"},{"end":"2022-06-30","val":24289000,"accn":"0000891293-22-000043","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-08","frame":"CY2022Q2I"},{"end":"2022-09-30","val":23757000,"accn":"0000891293-22-000054","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-07","frame":"CY2022Q3I"},{"end":"2022-12-31","val":23226000,"accn":"0000891293-23-000011","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-06"},{"end":"2022-12-31","val":23226000,"accn":"0000891293-23-000015","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15","frame":"CY2022Q4I"},{"end":"2023-03-31","val":22705000,"accn":"0000891293-23-000015","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15","frame":"CY2023Q1I"}]}}